- Home
- NUVB vs SBR Comparison
NUVB vs SBR Comparison
Compare NUVB & SBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- SBR
- Stock Information
- Founded
- NUVB 2018
- SBR 1982
- Country
- NUVB United States
- SBR United States
- Employees
- NUVB N/A
- SBR N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- SBR Oil & Gas Production
- Sector
- NUVB Health Care
- SBR Energy
- Exchange
- NUVB Nasdaq
- SBR Nasdaq
- Market Cap
- NUVB 1.1B
- SBR 1.1B
- IPO Year
- NUVB N/A
- SBR N/A
- Fundamental
- Price
- NUVB $5.04
- SBR $70.32
- Analyst Decision
- NUVB Strong Buy
- SBR
- Analyst Count
- NUVB 7
- SBR 0
- Target Price
- NUVB $8.43
- SBR N/A
- AVG Volume (30 Days)
- NUVB 8.2M
- SBR 52.2K
- Earning Date
- NUVB 11-03-2025
- SBR 01-01-0001
- Dividend Yield
- NUVB N/A
- SBR 7.64%
- EPS Growth
- NUVB N/A
- SBR N/A
- EPS
- NUVB N/A
- SBR 5.05
- Revenue
- NUVB $14,355,000.00
- SBR $77,682,730.00
- Revenue This Year
- NUVB $291.13
- SBR N/A
- Revenue Next Year
- NUVB $332.00
- SBR N/A
- P/E Ratio
- NUVB N/A
- SBR $13.93
- Revenue Growth
- NUVB 900.35
- SBR N/A
- 52 Week Low
- NUVB $1.54
- SBR $58.25
- 52 Week High
- NUVB $5.12
- SBR $84.39
- Technical
- Relative Strength Index (RSI)
- NUVB 76.90
- SBR 45.64
- Support Level
- NUVB $3.36
- SBR $66.80
- Resistance Level
- NUVB $3.84
- SBR $70.81
- Average True Range (ATR)
- NUVB 0.29
- SBR 1.68
- MACD
- NUVB 0.11
- SBR 0.04
- Stochastic Oscillator
- NUVB 95.45
- SBR 61.01
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
About SBR Sabine Royalty Trust
Sabine Royalty Trust is an express trust which is formed to receive Sabine Corporation's royalty and mineral interests, including landowner's royalties, overriding royalty interests, minerals production payments and any other similar, non-participatory interests, in certain Royalty Properties. The trusts producing and proved undeveloped oil and gas royalty properties are located in Florida, Louisiana, Mississippi, New Mexico, Oklahoma, and Texas.